The association among uric acid, microalbumin and estimated glomerular filtration rate in hypertensive patients: a case control study

Table 5 The multivariate linear regression analysis for Log 24 h-MAU and eGFR in subgroup analysis

Gender	Variates	Log 24 h-MAU				Variates	eGFR
Gender	Variates	B	SE	β	P	Variates	B	SE	β	P
Male	UA (every increased 10 μmol/L)	0.004	0.002	0.087	0.060	UA (every increased 10 μmol/L)	− 0.518	0.138	− 0.175	< 0.001
	BMI	0.010	0.006	0.077	0.096	Age	− 0.681	0.130	− 0.249	< 0.009
	Duration of hypertension					ACEI/ARB intake	− 4.991	2.599	− 0.089	0.055
	Less than 1 year	Reference				24 h mean DBP	− 0.308	0.102	− 0.138	0.003
	1–5 years	0.029	0.050	0.030	0.565
	5–10 years	0.159	0.062	0.127	0.010
	More than 10 years	0.105	0.065	0.081	0.109
	Grade 3 hypertension	0.170	0.044	0.176	< 0.001
	CCB intake	0.094	0.043	0.099	0.027
	Diuretic intake	0.126	0.068	0.081	0.065
	24 h mean SBP	0.005	0.001	0.156	0.001
	eGFR	− 0.002	0.001	− 0.105	0.017
Female	UA (every increased 10 μmol/L)	0.015	0.004	0.269	0.001	UA (every increased 10 μmol/L)	− 0.855	0.286	− 0.209	0.003
	24 h mean SBP	0.007	0.002	0.232	0.003	Age	− 0.911	0.173	− 0.409	< 0.001
						ACEI/ARB intake	− 11.915	4.716	− 0.188	0.013

Multivariate analysis was adjusted for age, BMI, duration of hypertension, grade of hypertension, smoking, alcohol intake, ACEI/ARB intake, β-blocker intake, CCB intake, diuretic intake, 24 h mean SBP, 24 h mean DBP, Log 24 h-MAU/eGFR and UA.
24 h-MAU: 24-h microalbuminuria; eGFR: estimated glomerular filtration rate; UA: uric acid; BMI: body mass index; ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin receptor inhibitor

ISSN: 1471-2261